ALIPAY
16.9.2021 04:29:11 CEST | Business Wire | Press release
Fintech training platform 10x1000 Tech for Inclusion announced that it will deepen its collaborations with partners worldwide, working with leading global organizations, tech investors, and industry organizations to offer a program that enables aspiring practitioners to learn from global experts at their own pace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915006200/en/
Available from October through grants to over 1,000 learners, the Fintech Foundation Program Flex is a fully online certificate program providing practitioners with the mindset, knowledge and skills to become drivers of digital economic growth, according to 10x1000, a global and philanthropic fintech training initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
Flex learners will be recruited through partners such as the IFC (including the SME Finance Forum), United Nations Economic Commission for Africa, Dubai International Financial Centre, Malaysia Digital Economy Corporation, KPMG and fintech associations from Hong Kong, Malaysia, the Philippines, Thailand, and Singapore. (See table for a full list of 10X1000 partners)
“We are delighted to join hands with global partners to bring the 10x1000 training platform to learners worldwide, as we seek innovative approaches to meeting a common goal of bridging the digital skills gap, particularly in communities that need it the most,” said Eric Jing, Chairman and CEO of Ant Group, owner and operator of digital payments platform Alipay. “I am excited that learners from 10x1000’s new Flex program will gain the fintech knowledge they need to support their communities, and help bring us closer to meeting the UN Sustainable Development Goals (SDGs).”
“IFC has been a steadfast supporter of digital innovations that foster financial inclusion. As nations emerge from the Covid-19 pandemic, the world is in need of more visionary fintech leaders to drive such innovation and expand financial access,” said Qamar Saleem, Regional Manager for Advisory Services, Financial Institutions Group, Asia and Pacific, IFC. “We believe 10x1000’s Flex program will bring distinct value to complement existing educational resources with a flexible curriculum that draws on practical experience of leading fintech practitioners across regions.”
Through eight recorded video lectures, attendees of the new Flex program will hear directly from tech entrepreneurs, senior leaders at Ant and other fintech firms as well as distinguished scholars, sharing their first-hand knowledge on topics ranging from ‘the tech behind fintech’ and best practices in leveraging technology to solve real business problems.
Training content provided by 10x1000 is being guided by a Curriculum Steering Committee (CSC), an advisory body responsible for ensuring the quality and effectiveness of the curriculum. The current committee is composed of global experts from industry, academia, and international financial institutions.
Going forward, 10x1000 will also work with partners and alumni to cultivate a global fintech community, creating a vibrant platform that provides opportunities for willing organizations and individuals to contribute to global financial inclusion.
About 10x1000
10x1000 Tech for Inclusion is an open and global fintech training platform that enables learners to become drivers of digital economic growth. Its mission is to train 1,000 emerging talents and tech leaders each year for the next ten years. 10x1000 is a philanthropic initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
** 10x1000 Tech for Inclusion Partners List **
Founding Partners
1. Alipay (Alipay)
2. IFC (International Finance Corporation)
Global Organizations
1. UNECA (United Nations Economic Commission for Africa)
2. UNWFP (United Nations World Food Programme)
3. SME Finance Forum (SME Finance Forum, Managed by the IFC)
Regional-Country Industry Organizations
1. Africa’s Business Heroes (ABH)
2. DIFC (Dubai International Financial Centre)
3. FTAHK (FinTech Association of Hong Kong)
4. FAOM (FinTech Association of Malaysia)
5. Fintech Alliance PH Inc (Fintech Alliance.ph)
6. MDEC (Malaysia Digital Economy Corporation)
7. MFTA (MENA Fintech Association)
8. SFA (Singapore FinTech Association)
9. SLT (She Loves Tech)
10. TFA (Thai Fintech Association)
Professional Services/Investors
1. BAce Capital (BAce Capital)
2. Gobi Partners (Gobi Partners)
3. KPMG (KPMG)
4. 917Ventures (917Ventures)
** 10x1000 Curriculum Steering Committee Members (2021) **
Nafez Dakkak
Executive Chairman, Edraak.org
Pooma Kimis
Director, Bernstein Autonomous
Qamar Saleem
Regional Industry Manager Asia & Pacific, Financial Institutions Group at International Finance Corporation (IFC)
Daniel Suen
Head of Strategy, International Education, General Manager, China Education, Wiley
View source version on businesswire.com: https://www.businesswire.com/news/home/20210915006200/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom